Proteo Inc

(PTEO)

By |

Profile

Proteo Inc operates as a clinical stage drug development company which engages in the development of anti-inflammatory treatments for rare diseases with unmet needs. It develops, promotes and market pharmaceuticals and other biotech products. The company is engaged in the development of pharmaceuticals based on the body's own tools and weapons to fight inflammatory diseases. It has obtained Orphan drug designations within the European Union for the use of Elafin for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension as well as for the treatment of esophageal cancer.

Contact Information

Website: www.inc.proteo.de
Main Phone: +1 949 253-4155
Address: 2102 Business Center Drive
State: CA
City / Town: Irvine
Country: USA
Postal Code: 92612

Issuer Information

Exchange: OTCQB
CEO: Birge Bargmann
Employees: 4
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.08 $ 0. (0.00%)
Last Price 0.08 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 0.08
Last Trade Volume 0 52 Wk Hi 0.08 52 Wk Low 0.03
Market Cap 1.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 23,879,350.00 EPS (TTM) 0.00 PE Ratio 13.00 Exchange OTCQB